Umberger Traci S
Umberger Traci S, SR, reported a transaction classified as exercise at KESTRA MEDICAL TECHNOLOGIES, LTD. involving 100000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 441000.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Oct 21, 2026
- Filing date
- Oct 22, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
KMTS price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-428980 Options
- Transaction date
- Oct 21, 2026 Filed Oct 22, 2026, 08:26 PM · 1d delay
- Shares
- 100,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 441,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
See Remarks
- F1
This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on July 21, 2026.
- F2
The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.8050 to $27.7927. Upon request, the reporting person will provide to the Issuer…
- F3
The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $27.8200 to $28.4200. Upon request, the reporting person will provide to the Issuer…
- F4
Includes 395,919 fully vested options as of the filing date, with the remaining 45,081 options vesting in equal monthly installments through March 6, 2027.
0 other transactions
0 recent txs